# S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

> **NCT00301886** · PHASE3 · WITHDRAWN · sponsor: **SWOG Cancer Research Network**

## Conditions studied

- Breast Cancer
- Hypercalcemia of Malignancy
- Metastatic Cancer
- Pain

## Interventions

- **DRUG:** ibandronate
- **DRUG:** zoledronate
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00301886
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-05
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn support for study
- **Last updated:** 2013-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301886, "S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00301886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*